vWF启动子表观遗传修饰驱动慢性血栓栓塞性肺动脉高压肺内皮血小板聚集
本研究探讨血管性血友病因子(vWF)在慢性血栓栓塞性肺动脉高压(CTEPH)中的作用。利用CTEPH患者血浆和肺动脉内膜切除组织,发现vWF在血浆和肺内皮中升高,内皮激活后vWF释放增加导致血小板黏附增强。蛋白组学显示NF-κB2显著增加,vWF启动子组蛋白三甲基化减少和乙酰化增加促进NF-κB2结合并驱动vWF转录,遗传干扰NF-κB2可逆转促血栓表型。结论提示vWF启动子表观遗传调控促进肺动脉原位血栓形成。
要点
- CTEPH患者血浆和肺内皮中vWF表达升高。
- vWF启动子表观遗传修饰促进NF-κB2结合并驱动转录。
- 干扰NF-κB2可逆转CTEPH内皮细胞的促血栓表型。
核心结论
- vWF启动子的表观遗传调控创建了利于肺动脉原位血栓形成的局部环境。
- 研究揭示了肺血管壁中炎症通路与血小板黏附之间的直接分子联系。
研究设计与样本
- 使用CTEPH患者血浆和肺动脉内膜切除材料研究炎症、vWF表达与肺血栓形成的关系。
- 细胞培养结果在人组织中得到验证,并采用蛋白组学和染色质免疫沉淀研究机制。
主要发现
- vWF在CTEPH患者血浆和肺内皮中增加。
- 体外实验显示内皮激活后vWF基因表达增加和vWF蛋白释放增多,导致血小板黏附到CTEPH内皮增加。
- 蛋白组学分析显示CTEPH中核因子(NF)-κB2显著增加。
- CTEPH内皮中vWF启动子组蛋白三甲基化减少和乙酰化增加,促进NF-κB2结合并驱动vWF转录。
- 遗传干扰NF-κB2使升高的vWF RNA表达正常化并逆转CTEPH肺动脉内皮细胞的促血栓表型。
临床怎么用
- 提示vWF及其表观遗传调控可能作为CTEPH血栓形成机制的干预靶点。
- 支持炎症通路与肺血管壁血小板黏附在CTEPH中的关联,可能指导抗血栓策略研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: von Willebrand factor (vWF) mediates platelet adhesion during thrombosis. While chronic thromboembolic pulmonary hypertension (CTEPH) is associated with increased plasma levels of vWF, the role of this protein in CTEPH has remained enigmatic. Objectives: To identify the role of vWF in CTEPH. Methods: CTEPH-specific patient plasma and pulmonary endarterectomy material from patients with CTEPH were used to study the relationship between inflammation, vWF expression, and pulmonary thrombosis. Cell culture findings were validated in human tissue, and proteomics and chromatin immunoprecipitation were used to investigate the underlying mechanism of CTEPH. Measurements and Main Results: vWF is increased in plasma and the pulmonary endothelium of CTEPH patients. In vitro, the increase in vWF gene expression and the higher release of vWF protein upon endothelial activation resulted in elevated platelet adhesion to CTEPH endothelium. Proteomic analysis revealed that nuclear factor (NF)-κB2 was significantly increased in CTEPH. We demonstrate reduced histone tri-methylation and increased histone acetylation of the vWF promoter in CTEPH endothelium, facilitating binding of NF-κB2 to the vWF promoter and driving vWF transcription. Genetic interference of NFκB2 normalized the high vWF RNA expression levels and reversed the prothrombotic phenotype observed in CTEPH-pulmonary artery endothelial cells. Conclusions: Epigenetic regulation of the vWF promoter contributes to the creation of a local environment that favors in situ thrombosis in the pulmonary arteries. It reveals a direct molecular link between inflammatory pathways and platelet adhesion in the pulmonary vascular wall, emphasizing a possible role of in situ thrombosis in the development or progression of CTEPH.
引用
- Manz XD, Szulcek R, Pan X, et al. Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension. Am J Respir Crit Care Med. 2022. PMID: 35081007. doi:10.1164/rccm.202109-2075OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。